Changing the way we age: Discovery could help preserve muscle strength

by Brian Consiglio, University of Missouri

edited by Swati Mestri, reviewed by Andrew Zinin

Swati Mestri

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

A groundbreaking discovery at the University of Missouri could help older adults maintain the muscle strength they need to stay active and independent, whether that means safely crossing the street or playing with their grandchildren.

The research is published in the Journal of Clinical Investigation.

W. David Arnold, the executive director of the NextGen Precision Health initiative, and his collaborators discovered that a previously unrecognized breakdown in the communication between nerves and muscles contributes to age-related muscle weakness, also known as sarcopenia, which affects nearly half of adults 80 and older.

The researchers also identified a protein that could be targeted to improve muscle strength, offering hope for those who have assumed a decline in muscle strength is simply an inevitable part of aging.

"While the human lifespan has increased in recent decades, our ultimate goal at Mizzou is to ensure a person's health span remains as high as possible for as long as possible," Arnold, a professor in the School of Medicine, said.

Scientists have long sought to understand what causes muscles to weaken as people age. One theory has focused on changes happening within the muscles themselves, most notably the loss of muscle mass. Researchers have also studied the loss of neurons that send messages telling muscles to move.

But Arnold wondered if something else was happening between the two.

For more than a decade, Arnold has studied the neuromuscular junction—the point where a nerve communicates with a muscle to make it contract. Normally, this communication is reliable, allowing signals from nerves to consistently trigger activation of muscle fibers.

Arnold's research found that this communication becomes less effective with age due to reduced levels of a protein called NaV1.4.

"A long-held assumption in the field was that the neuromuscular junction remains reliable during aging, and some even suggested it may get better with aging," Arnold said. "The significance of this new study is we are showing, in both humans and animal models, that the neuromuscular junction is failing with aging."

The discovery also gave Arnold and his team a potential target for restoring some of that lost muscle function.

"We identified an important point of failure at the final step in communication between nerves and muscles," Arnold said.

"And what is perhaps even more exciting is that we showed this failure is potentially reversible. In collaboration with NMD Pharma, a biotechnology company in Denmark, we applied an approach they developed that targets a protein called ClC-1. By partially inhibiting ClC-1, we were able to make aging muscles more responsive to nerve signals and improve muscle strength in an animal model. That gives us a potential path toward eventually testing this approach in older adults."

Turning discoveries into treatments

There is already evidence from clinical studies that targeting ClC-1 can improve aspects of muscle strength and function in people with neuromuscular disease, although those studies have focused on different conditions.

Arnold was an investigator in a multicenter clinical trial of ignaseclant, a drug candidate developed by NMD Pharma that partially inhibits ClC-1, in patients with Charcot-Marie-Tooth disease, the most common inherited neuromuscular disorder.

The study found improvements across several measures of muscle strength and function, and Arnold presented the topline results at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference.

Arnold is optimistic that ignaseclant could eventually help older adults with sarcopenia.

"I realized that in order to make a drug widely available to treat sarcopenia, the first step is to better understand what is causing sarcopenia in the first place," Arnold said. "That curiosity sparked my interest in becoming a researcher."

The work has brought together expertise from around the world. Arnold leads an international team of scientists and clinicians from Denmark, Scotland, Saudi Arabia and India. At Mizzou, he has also recruited researchers to the Roy Blunt NextGen Precision Health building, including Hiroshi Nishimune, an internationally renowned expert in neuromuscular junction research and co-author on the new study.

"When he came to Mizzou from Tokyo to join our lab, his specialized imaging expertise helped us start to answer questions that previously seemed out of reach," Arnold said. "He's really one of the top experts in the world when it comes to the neuromuscular junction, and it definitely gives us an edge here at Mizzou for pioneering innovative work in this field."

Publication details

W. David Arnold et al, Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition, Journal of Clinical Investigation (2026). DOI: 10.1172/jci190646

Journal information: Journal of Clinical Investigation

Key medical concepts

SarcopeniaNeuromuscular JunctionMuscle Strength

Clinical categories

NeurologyHealthy agingClinical pharmacology Provided by University of Missouri Who's behind this story?

Swati Mestri

Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Changing the way we age: Discovery could help preserve muscle strength (2026, September 22) retrieved 24 September 2026 from https://medicalxpress.com/news/2026-09-age-discovery-muscle-strength.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.